Your browser doesn't support javascript.
loading
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy.
Zubiri, Leyre; Allen, Ian M; Taylor, Martin S; Guidon, Amanda C; Chen, Steven T; Schoenfeld, Sara R; Neilan, Tomas G; Sise, Meghan E; Mooradian, Meghan J; Rubin, Krista M; Leaf, Rebecca Karp; Parikh, Aparna R; Faje, Alexander; Gainor, Justin F; Cohen, Justine V; Fintelmann, Florian J; Kohler, Minna J; Dougan, Michael; Reynolds, Kerry L.
Afiliação
  • Zubiri L; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Allen IM; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Taylor MS; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Guidon AC; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Chen ST; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Schoenfeld SR; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Neilan TG; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Sise ME; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Mooradian MJ; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Rubin KM; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Leaf RK; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Parikh AR; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Faje A; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Gainor JF; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Cohen JV; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Fintelmann FJ; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kohler MJ; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Dougan M; Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reynolds KL; Massachusetts General Hospital, Boston, Massachusetts, USA.
Oncologist ; 25(3): e398-e404, 2020 03.
Article em En | MEDLINE | ID: mdl-32162817

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article